Katherine E. Byrne
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Katherine E. Byrne has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- B. Pradeep Kumar Reddy
School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, USA
2 shared publications - Gianna Fiduccia
School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, USA
2 shared publications - Mark R. Prausnitz
School of Chemical and Biomolecular Engineering Georgia Institute of Technology Atlanta Georgia USA
2 shared publications - Sophia H. Sakers
Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine, Atlanta, USA
2 shared publications - Afsane Radmand
School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, USA
1 shared publication - Ingrid Stén
School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, USA
1 shared publication
Latest Publications
- Open Access
- 2 September 2025
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 16 (7) , 2256-2271
Development of a microneedle patch for delivery of mRNA-lipid nanoparticles
MRNA delivered by microneedle patch (MNP) can enable painless delivery, reduced need for healthcare expertise, and improved thermostability. In this study, we investigated formulation and manufacturing approaches for developing MNPs that deliver mRNA-loaded lipid nanoparticles (LNPs) encoding luciferase as a reporter protein during MNP fabrication and storage, including mRNA-LNP concentration, formulation, pH, excipients, and backing material. MNPs were assessed for mRNA-LNP size, encapsulation efficiency, and protein expression in vitro and in vivo. MNPs fabricated with mRNA-LNPs initially prepared at a higher concentration yielded superior expression compared to mRNA-LNP concentration by centrifugation or tangential flow filtration. Acidic pH during MNP manufacturing enabled greater expression in vitro. However, no such correlation was observed in vivo. Polyvinyl alcohol (PVA) best stabilized mRNA-LNPs during the MNP manufacturing process amongst the tested polymers. Incorporating sugars in MNPs did not further improve stability. Low temperature drying (5 °C) preserved mRNA functionality better compared to drying at 25 °C and 40 °C. Though there was significant activity loss initially (87% loss in 2 days at 40 °C), mRNA expression was stabilized for extended subsequent periods even at accelerated conditions (10% additional loss after 28 days at 40 °C). Our systematic approach identified key parameters for successful formulation and manufacturing approaches to incorporate mRNA-LNPs into MNPs, which could expand access to mRNA-based medical interventions.
- 2 September 2025
- Published by Springer Nature in Drug Delivery and Translational Research
- Vol. 16 (7) , 2256-2271
Open AccessDevelopment of a microneedle patch for delivery of mRNA-lipid nanoparticles
MRNA delivered by microneedle patch (MNP) can enable painless delivery, reduced need for healthcare expertise, and improved thermostability. In this study, we investigated formulation and manufacturing approaches for developing MNPs that deliver mRNA-loaded lipid nanoparticles (LNPs) encoding luciferase as a reporter protein during MNP fabrication and storage, including mRNA-LNP concentration, formulation, pH, excipients, and backing material. MNPs were assessed for mRNA-LNP size, encapsulation efficiency, and protein expression in vitro and in vivo. MNPs fabricated with mRNA-LNPs initially prepared at a higher concentration yielded superior expression compared to mRNA-LNP concentration by centrifugation or tangential flow filtration. Acidic pH during MNP manufacturing enabled greater expression in vitro. However, no such correlation was observed in vivo. Polyvinyl alcohol (PVA) best stabilized mRNA-LNPs during the MNP manufacturing process amongst the tested polymers. Incorporating sugars in MNPs did not further improve stability. Low temperature drying (5 °C) preserved mRNA functionality better compared to drying at 25 °C and 40 °C. Though there was significant activity loss initially (87% loss in 2 days at 40 °C), mRNA expression was stabilized for extended subsequent periods even at accelerated conditions (10% additional loss after 28 days at 40 °C). Our systematic approach identified key parameters for successful formulation and manufacturing approaches to incorporate mRNA-LNPs into MNPs, which could expand access to mRNA-based medical interventions.
- Open Access
- 8 August 2025
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 215, 114819
The effect of mRNA-lipid nanoparticle composition on stability during microneedle patch manufacturing
- 8 August 2025
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 215, 114819
Open AccessThe effect of mRNA-lipid nanoparticle composition on stability during microneedle patch manufacturing